SEARCH RESULT

Total Matching Records found : 1363

UPA struggles to put life into annual report-Sanjay K Jha

The UPA II’s third anniversary on May 22 may witness a repackaging of old schemes, promises and achievements in the “Report to the people” as the government has little to show for 2011-12. Sources say the 13-chapter report struggles to contest the perception of policy paralysis by pointing out social-sector initiatives based primarily on welfare schemes launched during the UPA I regime or in the first year of UPA II. The government...

More »

NRHM scam: Note ‘implicates’ Mayawati

-The Times of India Fingers are now being pointed at former chief minister Mayawati and her favourite babu Shashank Shekhar Singh for the role they might have played in the National Rural Health Mission (NRHM) scam. And the basis for this is a government order issued by Mayawati herself on May 31, 2007, 18 days after becoming chief minister. Although the BSP on Wednesday denied any role of its supremo in the...

More »

Abortion as a feminist issue: Who decides and what?-Nivedita Menon

There is a complicated relationship between abortion as such and the selective abortion of female foetuses. This dilemma is one with which the women’s movement in India has been grappling since the late 1980s. In my discussion of this dilemma, I would like to move away completely from Satyamev Jayate, the television programme, (on which a discussion has been initiated by Shohini Ghosh on kafila.org). In any case, there the...

More »

The government needs to think out of the box to help pharma grow while keeping medicines affordable-Ramesh Adige

Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...

More »

A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcare-David Taylor

The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close